A multicenter analysis of prognostic factors in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib.

被引：0
|
作者：
Smith, Alan D.
Chan, Kelvin K.
Lim, Howard John
Cheung, Winson Y.
机构：
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[2] Princess Margaret Hosp, Sunnybrook Odette Canc Ctr, Toronto, ON M4X 1K9, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14532
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study.
    Marasco, Giovanni
    Colecchia, Antonio
    Reggiani, Maria Letizia Bacchi
    Celsa, Ciro
    Farinati, Fabio
    Giannini, Edoardo Giovanni
    Benevento, Francesca
    Rapaccini, Gian Ludovico
    Caturelli, Eugenio
    Di Marco, Mariella
    Biasini, Elisabetta
    Marra, Fabio
    Morisco, Filomena
    Foschi, Francesco Giuseppe
    Zoli, Marco
    Gasbarrini, Antonio
    Baroni, Gianluca Svegliati
    Masotto, Alberto
    Sacco, Rodolfo
    Raimondo, Giovanni
    Azzaroli, Francesco
    Mega, Andrea
    Vidili, Gianpaolo
    Brunetto, Maurizia Rossana
    Nardone, Gerardo
    Dajti, Elton
    Ravaioli, Federico
    Avanzato, Francesca
    Festi, Davide
    Trevisani, Franco
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (08) : 1011 - 1019
  • [32] Pretreatment neutrophil to lymphocyte ratio and prognosis of patients with advanced hepatocelullar carcinoma treated with sorafenib.
    Fonseca, Leonardo Gomes
    Barroso-Sousa, Romualdo
    Blanco, Bruna Paccola
    Valente, Gabriel Luls
    Freltas Melro Braghlroll, Maria Ignez
    Flesch Pfiffer, Tullo Eduardo
    Sabbaga, Jorge
    Hoff, Paulo Marcelo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] TIME TO PROGRESSION OF AFP IS AN INDEPENDENT PROGNOSTIC FACTOR OF SURVIVAL IN HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB. INTERNAL VALIDATION
    Varela, M.
    Blanco-Garcia, L.
    Castano-Fernandez, O.
    Gonzalez-Dieguez, M. L.
    Cadahia-Rodrigo, V.
    Alvarez-Navascues, C.
    Perez-Alvarez, R.
    Mesa, A.
    Hernandez-Luyando, L.
    Rodriguez, M.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S454 - S454
  • [34] Clinical outcome and prognostic factors of patients with hepatocellular carcinoma and extrahepatic metastasis treated with sorafenib
    Kawaoka, Tomokazu
    Aikata, Hiroshi
    Kan, Hiromi
    Fujino, Hatsue
    Fukuhara, Takayuki
    Kobayashi, Tomoki
    Naeshiro, Noriaki
    Miyaki, Daisuke
    Hiramatsu, Akira
    Imamura, Michio
    Kawakami, Yoshiiku
    Hyogo, Hideyuki
    Chayama, Kazuaki
    HEPATOLOGY RESEARCH, 2014, 44 (13) : 1320 - 1328
  • [35] A single center experience of sorafenib in advanced hepatocellular carcinoma patients: evaluation of prognostic factors
    Song, Tianqiang
    Zhang, Wei
    Wu, Qiang
    Kong, Dalu
    Ma, Weiwei
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (12) : 1233 - 1238
  • [36] Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib
    Sansone, Vito
    Tovoli, Francesco
    Casadei-Gardini, Andrea
    Di Costanzo, Giovan Giuseppe
    Magini, Giulia
    Sacco, Rodolfo
    Pressiani, Tiziana
    Trevisani, Franco
    Rimini, Margherita
    Tortora, Raffaella
    Nardi, Elena
    Ielasi, Luca
    Piscaglia, Fabio
    Granito, Alessandro
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (01)
  • [37] A phase II study of TR105 in patients with hepatocellular carcinoma (HCC) who have progressed on sorafenib.
    Duffy, Austin G.
    Rahma, Osama E.
    Ulahannan, Susanna Varkey
    Fioravanti, Suzanne
    Venkatesan, Aradhana
    Turkbey, Ismail B.
    Choyke, Peter L.
    Trepel, Jane B.
    Figg, William Douglas
    Greten, Tim F.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [38] A simple prognostic scoring system for patients treated with sorafenib for advanced hepatocellular Carcinoma: The SAP score
    Edeline, J.
    Blanc, J. F.
    King, J.
    Chatterjee, M.
    Mathurin, J.
    Le Sourd, S.
    Palmer, D.
    Meyer, T.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S443 - S444
  • [39] An internally validated new clinical prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib
    Bruixola, G.
    Diaz Beveridge, R.
    Nino, O. M.
    Reche, E.
    Salvador, C.
    Escoin, C.
    Akhoundova, D.
    Segura, A.
    Gimenez, A.
    Aparicio, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S441 - S441
  • [40] Efficacy and Prognostic Factors of Sorafenib Targeted Therapy for Advanced Hepatocellular Carcinoma
    Sun Long
    Yang Shiwei
    Fang Qing
    Liu Ping
    Zhang Rongjie
    Hu Chunfang
    Hao Yingxue
    LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (01): : 120 - 125
12345